Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study
- PMID: 23580693
- DOI: 10.1136/bmj.f1865
Persistent pain and sensory disturbances after treatment for breast cancer: six year nationwide follow-up study
Abstract
Objective: To examine the development of persistent pain after treatment for breast cancer and to examine risk factors associated with continuing pain.
Design: Repeated cross sectional study in a previously examined nationwide cohort. All eligible women who underwent surgery for primary breast cancer in Denmark in 2005 and 2006 and were examined in 2008 were surveyed again with the same questionnaire.
Setting: Surgical centres in Denmark.
Main outcome measures: Prevalence, location, and severity of persistent pain after treatment for breast cancer in well defined treatment groups and changes in pain reporting and sensory disturbances from 2008 to 2012.
Participants: In 2012, 2828 women were eligible in our database, and 108 were excluded. Exclusion criteria were death; new, recurrent, or other cancer; reconstructive breast surgery; and emigration.
Results: 2411 (89%) women returned the questionnaire. Prevalence of persistent pain after treatment for breast cancer ranged from 22% to 53% depending on treatment. In 2012, 903 (37%) women reported such pain, a fall from 45% in 2008. Of these, 378 (16%) reported pain of ≥ 4 on a numerical rating scale (scale 0-10), a fall from 19%. Among women reporting pain in 2008, 36% no longer reported it in 2012. In contrast, 15% of the women who did not report pain in 2008 reported it in 2012. Risk factors for having pain were axillary lymph node dissection rather than sentinel lymph node biopsy (odds ratio 2.04, 95% confidence interval 1.60 to 2.61; P<0.001) and age ≤ 49 (1.78, 1.25 to 2.54; P<0.001). No particular method of treatment or age was associated with an increase in pain from 2008 to 2012.
Conclusions: Persistent pain after treatment for breast cancer remains an important problem five to seven years later. The problem is not static as it can either progress or regress with time.
Trial registration: Clinicaltrials.gov NCT No 01543711.
Trial registration: ClinicalTrials.gov NCT01543711.
Comment in
-
Five to seven years after breast cancer treatment, over a third of women (37%) report persistent pain.Evid Based Nurs. 2014 Apr;17(2):41-2. doi: 10.1136/eb-2013-101418. Epub 2013 Aug 12. Evid Based Nurs. 2014. PMID: 23939761 No abstract available.
Similar articles
-
Prevalence of and factors associated with persistent pain following breast cancer surgery.JAMA. 2009 Nov 11;302(18):1985-92. doi: 10.1001/jama.2009.1568. JAMA. 2009. PMID: 19903919
-
Persistent pain, sensory disturbances and functional impairment after immediate or delayed axillary lymph node dissection.Eur J Surg Oncol. 2013 Jan;39(1):31-5. doi: 10.1016/j.ejso.2012.10.010. Epub 2012 Oct 26. Eur J Surg Oncol. 2013. PMID: 23107434
-
Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7-9 years after surgery: a nationwide prospective study of women treated for primary breast cancer.Breast Cancer Res Treat. 2015 Aug;152(3):645-58. doi: 10.1007/s10549-015-3497-x. Epub 2015 Jul 19. Breast Cancer Res Treat. 2015. PMID: 26189085
-
Prevalence and intensity of persistent post-surgical pain following breast cancer surgery: a systematic review and meta-analysis of observational studies.Br J Anaesth. 2020 Sep;125(3):346-357. doi: 10.1016/j.bja.2020.04.088. Epub 2020 Jun 28. Br J Anaesth. 2020. PMID: 32611524
-
Treating Persistent Pain After Breast Cancer Surgery.Drugs. 2020 Jan;80(1):23-31. doi: 10.1007/s40265-019-01227-5. Drugs. 2020. PMID: 31784873 Review.
Cited by
-
Exploring women's experiences with persistent pain and pain management following breast cancer treatment: A qualitative study.Front Pain Res (Lausanne). 2023 Feb 13;4:1095377. doi: 10.3389/fpain.2023.1095377. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 36860333 Free PMC article.
-
Single shot ultrasound-guided thoracic paravertebral block for opioid-free radical mastectomy: a prospective observational study.J Pain Res. 2019 Sep 11;12:2701-2708. doi: 10.2147/JPR.S211944. eCollection 2019. J Pain Res. 2019. PMID: 31571975 Free PMC article.
-
Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors.Breast Cancer Res Treat. 2013 Jul;140(1):159-76. doi: 10.1007/s10549-013-2594-y. Breast Cancer Res Treat. 2013. PMID: 23797178 Free PMC article.
-
The quality of life of Croatian women after mastectomy: a cross-sectional single-center study.BMC Public Health. 2018 Aug 10;18(1):999. doi: 10.1186/s12889-018-5929-0. BMC Public Health. 2018. PMID: 30097040 Free PMC article.
-
Efficacy and Safety of Topical Morphine: A Narrative Review.Pharmaceutics. 2022 Jul 19;14(7):1499. doi: 10.3390/pharmaceutics14071499. Pharmaceutics. 2022. PMID: 35890392 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical